Concepedia

Publication | Open Access

Epcoritamab induces potent anti-tumor activity against malignant B-cells from patients with DLBCL, FL and MCL, irrespective of prior CD20 monoclonal antibody treatment

DOIFull Paper Access

94

Citations

16

References

2021

Year

Hilma J. van der Horst, A. Vera de Jonge, Ida H. Hiemstra, Anne T. Gelderloos, Daniella R. A. I. Berry, Nathalie J. Hijmering, Hendrik F. van Essen, Daphne de Jong, Martine E.D. Chamuleau, Sonja Zweegman,
Blood Cancer Journal

References

YearCitations

Page 1